I was reading an article which is linked below and I found this section really interesting.
“Zelira has also patented what we thought couldn’t be owned: the formulation that stipulates the ratio of tetrahydrocannabinol (THC) to the cannabidiol (CBD).”
So if the Zelira formulation has the perfect ratio of thc to cbd to treat a certain condition then no other company can sell that ratio? Sounds too good to be true!
https://unauthorised investment advice/health/dr-borehams-crucible-zeliras-share-price-could-wake-up-once-sales-of-its-pot-based-insomnia-drug-start/
Nice Buy..., page-36
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.0¢ |
Change
0.005(0.68%) |
Mkt cap ! $8.396M | |||
| Open | High | Low | Value | Volume |
| 72.0¢ | 74.0¢ | 72.0¢ | $5.362K | 7.296K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10537 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 74.0¢ | 72 | 1 |
View Market Depth
| Last trade - 15.59pm 18/09/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |